NCT07338448

Brief Summary

This study will compare the effects of transcutaneous acupoint electrical stimulation versus no stimulation on intraoperative gastric reflux in patients undergoing general anesthesia with i-gel airway device ventilation.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
116

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started Jan 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Jan 2026Jul 2026

First Submitted

Initial submission to the registry

January 3, 2026

Completed
9 days until next milestone

Study Start

First participant enrolled

January 12, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 13, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Last Updated

January 13, 2026

Status Verified

January 1, 2026

Enrollment Period

7 months

First QC Date

January 3, 2026

Last Update Submit

January 3, 2026

Conditions

Keywords

acupoint stimulationgeneral anesthesiagastric refluxigel

Outcome Measures

Primary Outcomes (1)

  • pH value at middle-esophageal part at end of surgery

    at end of surgery

Secondary Outcomes (5)

  • number of gastric reflux episodes

    from intubation of igel to end of surgery, at an average of 2 hours

  • total duration of gastric reflux episodes

    from intubation of igel to end of surgery, at an average of 2 hours

  • longest duration of gastric reflux episodes

    from intubation of igel to end of surgery, at an average of 2 hours

  • pH value at glottis at the end of surgery

    at end of surgery

  • percentage of patients suffering postoperative nausea and vomiting by 24 hours after surgery

    from end of surgery to 24 hours after surgery

Study Arms (2)

Electrical stimulation

EXPERIMENTAL

Electrodes are pasted at the Neiguan, Zusanli, Gongsun, Taichong acupoints and electrical stimulation is given from anesthesia induction to end of surgery

Other: transcutaneous electrical acupoint stimulationOther: electrodes attachment

Control

PLACEBO COMPARATOR

Electrodes are pasted at the Neiguan, Zusanli, Gongsun, Taichong acupoints but no electrical stimulation is given

Other: electrodes attachment

Interventions

electrical stimulation at 2Hz/10Hz is given from induction to end of surgery

Electrical stimulation

Electrodes are pasted to the skin of Neiguan, Zusanli, Gongsun, Taichong acupoints

ControlElectrical stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age ≥18 years old
  • scheduled for surgery under general anesthesia with igel ventilation

You may not qualify if:

  • American society of anesthesiologists status higher than grade 3
  • history of gastrointestinal surgery
  • Currently taking acidic medications, or medications that affect gastric acid secretion or gastrointestinal motility
  • High risk of reflux or aspiration (e.g., symptomatic gastroesophageal reflux disease or hiatal hernia)
  • History of postoperative nausea and vomiting (PONV)
  • Intraoperative requirement of Trendelenburg position
  • Expected surgery duration exceeding 4 hours
  • Contraindications for acupoint electrical stimulation, such as patients with implanted electrophysiological devices, or skin infection/lesions at acupoint sites

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Gastroesophageal RefluxIge Responsiveness, Atopic

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 3, 2026

First Posted

January 13, 2026

Study Start

January 12, 2026

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

January 13, 2026

Record last verified: 2026-01